• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Kraig Biocraft to open new biotechnology research and production center

Kraig Biocraft to open new biotechnology research and production center

October 2, 2017
CenterWatch Staff

Kraig Biocraft Laboratories, a developer of spider silk based fibers, announced the company is opening its new research and production headquarters in Michigan. This facility will unite the company’s ongoing recombinant spider silk production operations with its accelerating research into the creation of ever more powerful spider silk protein technologies.

Over the next 30 days, the company will be relocating its current production operations, from Indiana into its new larger facility, and will transfer key production staff, to ensure continuity of operations. This new facility offers better environmental control, roughly three times the production space, significantly reduces overhead costs, and, for the first time in the company’s history, will allow the company’s research and production teams to work side by side producing today’s spider silk based products, and creating tomorrow’s possibilities.

The company created two new lead positions within its research group to support the new facility and growing research efforts.

“Launching this new larger factory unifies our production and research teams’ efforts. Having our teams working hand in hand will make us more agile and open up opportunities to move technologies more quickly from the drawing board to tested and validated designs,” said COO Jon Rice. “In addition to streamlining developmental timelines and enhancing our ability to tailor fibers, we expect to reduce R&D costs, as we generate new spider silk technologies by fully integrating design, creation, testing, and scale up, under a single roof. Our plan is to have this facility be the global central hub for spider silk technology and the center of our international operations.”

The company’s domestic operations complement its ongoing work establishing international production centers. Company management is currently considering three overseas locations for production. Management is scheduled for meeting with senior central government officials in Hanoi, Vietnam in early October and is in ongoing discussions with another country silk producing country which has expressed interest in working with the Company to scale its spider silk technology.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing